Prescription Drugs Introduced to Market
This dataset provides data for new prescription drugs introduced to market in California with a Wholesale Acquisition Cost (WAC) that exceeds the Medicare Part D specialty drug cost threshold. Prescription drug manufacturers submit information to HCAI within a specified time period after a drug is introduced to market. Key data elements include the National Drug Code (NDC) administered by the FDA, a narrative description of marketing and pricing plans, and WAC, among other information. Manufacturers may withhold information that is not in the public domain. Note that prescription drug manufacturers are able to submit new drug reports for a prior quarter at any time. Therefore, the data set may include additional new drug report(s) from previous quarter(s).
There are two types of New Drug data sets: Monthly and Annual. The Monthly data sets include the data in completed reports submitted by manufacturers for calendar year 2025, as of January 12, 2026. The Annual data sets include data in completed reports submitted by manufacturers for the specified year. The data sets may include reports that do not meet the specified minimum thresholds for reporting.
The program regulations are available here: https://hcai.ca.gov/wp-content/uploads/2024/03/CTRx-Regulations-Text.pdf
The data format and file specifications are available here: https://hcai.ca.gov/wp-content/uploads/2024/03/Format-and-File-Specifications-version-2.0-ada.pdf
DATA NOTES: Due to recent changes in Excel capabilities, it is not recommended that you save these files to .csv format. If you do, when importing back into Excel the leading zeros in the NDC number column will be dropped. If you need to save it into a different format other than .xlsx it must be .txt
Submitted reports that are still under review by HCAI are not included in these files.
DATA UPDATES: Drug manufacturers may submit New Drug reports to HCAI for prescription drugs which were not initially reported when they were introduced to market. CTRx staff update the posted datasets monthly for current year data and as needed for previous years. Please check the 'Data last updated' date on each dataset page to ensure you are viewing the most current data.
Complete Metadata
| @type | dcat:Dataset |
|---|---|
| accessLevel | public |
| contactPoint |
{
"fn": "Cost Transparency Rx",
"@type": "vcard:Contact",
"hasEmail": "mailto:ctrx@hcai.ca.gov"
}
|
| description | This dataset provides data for new prescription drugs introduced to market in California with a Wholesale Acquisition Cost (WAC) that exceeds the Medicare Part D specialty drug cost threshold. Prescription drug manufacturers submit information to HCAI within a specified time period after a drug is introduced to market. Key data elements include the National Drug Code (NDC) administered by the FDA, a narrative description of marketing and pricing plans, and WAC, among other information. Manufacturers may withhold information that is not in the public domain. Note that prescription drug manufacturers are able to submit new drug reports for a prior quarter at any time. Therefore, the data set may include additional new drug report(s) from previous quarter(s). There are two types of New Drug data sets: Monthly and Annual. The Monthly data sets include the data in completed reports submitted by manufacturers for calendar year 2025, as of January 12, 2026. The Annual data sets include data in completed reports submitted by manufacturers for the specified year. The data sets may include reports that do not meet the specified minimum thresholds for reporting. The program regulations are available here: https://hcai.ca.gov/wp-content/uploads/2024/03/CTRx-Regulations-Text.pdf The data format and file specifications are available here: https://hcai.ca.gov/wp-content/uploads/2024/03/Format-and-File-Specifications-version-2.0-ada.pdf DATA NOTES: Due to recent changes in Excel capabilities, it is not recommended that you save these files to .csv format. If you do, when importing back into Excel the leading zeros in the NDC number column will be dropped. If you need to save it into a different format other than .xlsx it must be .txt Submitted reports that are still under review by HCAI are not included in these files. DATA UPDATES: Drug manufacturers may submit New Drug reports to HCAI for prescription drugs which were not initially reported when they were introduced to market. CTRx staff update the posted datasets monthly for current year data and as needed for previous years. Please check the 'Data last updated' date on each dataset page to ensure you are viewing the most current data. |
| distribution |
[
{
"@type": "dcat:Distribution",
"title": "Q1-Q4 2022 Prescription Drugs Introduced to Market",
"format": "XLSX",
"mediaType": "application/vnd.openxmlformats-officedocument.spreadsheetml.sheet",
"describedBy": "https://data.ca.gov/api/action/datastore_search?resource_id=2dd3baed-bf97-4f6f-a795-7d1b6924d0a7&limit=0",
"downloadURL": "https://data.chhs.ca.gov/dataset/e54d331c-65d3-4c6e-b4ba-390bd7024248/resource/11a91095-1597-4b6a-b0b3-09e76422ce40/download/q1-q4-2022-prescription-drugs-introduced-to-market.xlsx",
"describedByType": "application/json"
},
{
"@type": "dcat:Distribution",
"title": "Q1-Q4 2023 Prescription Drugs Introduced to Market",
"format": "XLSX",
"mediaType": "application/vnd.openxmlformats-officedocument.spreadsheetml.sheet",
"describedBy": "https://data.ca.gov/api/action/datastore_search?resource_id=359790f3-9050-41b4-ad28-6d661e6f442c&limit=0",
"downloadURL": "https://data.chhs.ca.gov/dataset/e54d331c-65d3-4c6e-b4ba-390bd7024248/resource/f0899438-0fb5-42d5-87f5-621e2f0b1b51/download/q1-q4-2023-prescription-drugs-introduced-to-market.xlsx",
"describedByType": "application/json"
},
{
"@type": "dcat:Distribution",
"title": "Q1-Q4 2021 Prescription Drugs Introduced to Market",
"format": "XLSX",
"mediaType": "application/vnd.openxmlformats-officedocument.spreadsheetml.sheet",
"describedBy": "https://data.ca.gov/api/action/datastore_search?resource_id=5059c2d0-f238-4ea8-976d-c842a39d375a&limit=0",
"downloadURL": "https://data.chhs.ca.gov/dataset/e54d331c-65d3-4c6e-b4ba-390bd7024248/resource/5a80b890-24bb-4d66-a0bb-d6c46a150065/download/q1-q4-2021-prescription-drugs-introduced-to-market.xlsx",
"describedByType": "application/json"
},
{
"@type": "dcat:Distribution",
"title": "Q1-Q4 2020 Prescription Drugs Introduced to Market",
"format": "XLSX",
"mediaType": "application/vnd.openxmlformats-officedocument.spreadsheetml.sheet",
"describedBy": "https://data.ca.gov/api/action/datastore_search?resource_id=5aa3661b-9180-4097-8907-1324cf91e784&limit=0",
"downloadURL": "https://data.chhs.ca.gov/dataset/e54d331c-65d3-4c6e-b4ba-390bd7024248/resource/9a37709e-4151-4300-a031-91ea7813da60/download/q1-q4-2020-prescription-drugs-introduced-to-market.xlsx",
"describedByType": "application/json"
},
{
"@type": "dcat:Distribution",
"title": "Data Dictionary - Prescription Drugs Introduced to Market",
"format": "CSV",
"mediaType": "text/csv",
"describedBy": "https://data.ca.gov/api/action/datastore_search?resource_id=73d61ccb-5513-4007-adbf-1d1096df3fe0&limit=0",
"downloadURL": "https://data.chhs.ca.gov/dataset/e54d331c-65d3-4c6e-b4ba-390bd7024248/resource/74c10fe7-1b66-4288-b870-9ea3db310b26/download/new-prescription-drug-data-dictionary.csv",
"describedByType": "application/json"
},
{
"@type": "dcat:Distribution",
"title": "Q1-Q4 2019 Prescription Drugs Introduced to Market",
"format": "XLSX",
"mediaType": "application/vnd.openxmlformats-officedocument.spreadsheetml.sheet",
"describedBy": "https://data.ca.gov/api/action/datastore_search?resource_id=8d135b25-ca52-4c10-835a-7e59307f6699&limit=0",
"downloadURL": "https://data.chhs.ca.gov/dataset/e54d331c-65d3-4c6e-b4ba-390bd7024248/resource/6393cda0-6101-424e-b738-07aee9e6f94f/download/q1-q4-2019-prescription-drugs-introduced-to-market.xlsx",
"describedByType": "application/json"
},
{
"@type": "dcat:Distribution",
"title": "Q1-Q4 2024 Prescription Drugs Introduced to Market",
"format": "XLSX",
"mediaType": "application/vnd.openxmlformats-officedocument.spreadsheetml.sheet",
"describedBy": "https://data.ca.gov/api/action/datastore_search?resource_id=99c3356d-262e-4940-a33a-1a0ec5c259f4&limit=0",
"downloadURL": "https://data.chhs.ca.gov/dataset/e54d331c-65d3-4c6e-b4ba-390bd7024248/resource/0e3afcfc-a5eb-41c6-a633-deaa2bfb5710/download/q1-q4-2024-prescription-drugs-introduced-to-market.xlsx",
"describedByType": "application/json"
},
{
"@type": "dcat:Distribution",
"title": "Data Dictionary - Q1-Q4 2019 Prescription Drugs Introduced to Market",
"format": "CSV",
"mediaType": "text/csv",
"description": "Data Dictionary for https://data.chhs.ca.gov/dataset/e54d331c-65d3-4c6e-b4ba-390bd7024248/resource/6393cda0-6101-424e-b738-07aee9e6f94f/download/q1-q4-2019-prescription-drugs-introduced-to-market.xlsx",
"downloadURL": "https://data.ca.gov/datastore/dictionary_download/8d135b25-ca52-4c10-835a-7e59307f6699",
"isDataDictionary": true
},
{
"@type": "dcat:Distribution",
"title": "January 2026 Monthly Update (Q1-Q4 2025 data) - Prescription Drugs Introduced to Market (CSV)",
"format": "CSV",
"mediaType": "text/csv",
"downloadURL": "https://data.chhs.ca.gov/dataset/e54d331c-65d3-4c6e-b4ba-390bd7024248/resource/2be5663e-8862-42e8-bd0e-3476d8baf7c3/download/new-drug-data-q1-q4-2025.csv"
},
{
"@type": "dcat:Distribution",
"title": "January 2026 Monthly Update (Q1-Q4 2025 data) - Prescription Drugs Introduced to Market (Excel)",
"format": "XLSX",
"mediaType": "application/vnd.openxmlformats-officedocument.spreadsheetml.sheet",
"downloadURL": "https://data.chhs.ca.gov/dataset/e54d331c-65d3-4c6e-b4ba-390bd7024248/resource/4cf317a8-c7a4-40b7-8fa0-13fcad2ad0a2/download/new-drug-data-q1-q4-2025.xlsx"
},
{
"@type": "dcat:Distribution",
"title": "All resource data",
"format": "ZIP",
"mediaType": "application/zip",
"downloadURL": "https://data.chhs.ca.gov/dataset/e54d331c-65d3-4c6e-b4ba-390bd7024248/resource/82883221-f421-4b0f-90b6-616cee618e6a/download/prescription-drugs-introduced-to-market-i50xq9u7.zip"
}
]
|
| identifier | 8a017dbf-7a20-4899-889c-ca0b8283a767 |
| issued | 2019-03-05T16:45:32.819450 |
| keyword |
[
"CTRx",
"cost transparency",
"department of health care access and information",
"prescription drugs",
"sb17"
]
|
| license | http://www.opendefinition.org/licenses/cc-by |
| modified | 2026-01-12T17:36:05.075423 |
| publisher |
{
"name": "Department of Health Care Access and Information",
"@type": "org:Organization"
}
|
| theme |
[
"Health and Human Services"
]
|
| title | Prescription Drugs Introduced to Market |
